MyFinsight
Home
Blog
About
Contact
Download
Download image
Net (loss)
-$77,651,843
(-2409.20%↓ Y/Y)
Loss from continuing
operations
-$77,646,737
(-3300.47%↓ Y/Y)
Gain from
discontinued operations
-$5,106
(99.37%↑ Y/Y)
Other income
$2,631
(-92.77%↓ Y/Y)
Gain (loss) on
derivative instruments
-$74,366,000
(-1062371528.57%↓ Y/Y)
Total operating
(loss)
-$3,279,864
(-41.74%↓ Y/Y)
Other expense
$3,504
(-39.81%↓ Y/Y)
Total operating
expenses
$3,275,126
(32.99%↑ Y/Y)
Gross profit (loss)
-$4,738
(-103.18%↓ Y/Y)
Revenue
$3,618
(-98.95%↓ Y/Y)
General and
administrative
$2,613,075
(65.11%↑ Y/Y)
Operations, research and
development
$528,557
(-16.56%↓ Y/Y)
Sales and marketing
$133,494
(-45.88%↓ Y/Y)
Cost of sales
$8,356
(-95.76%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Predictive Oncology Inc. (POAI)
Predictive Oncology Inc. (POAI)